Prognosis Value of Transient Elastography and Non-invasive Markers of Fibrosis in Patients With Chronic Liver Disease (PVTE)

Association HGE CHU Bordeaux Sud

Status: Completed

Conditions: Liver Fibrosis

Study type: Observational

Funder types: Other

Identifiers

NCT01241227

HLV-0403

Details and patient eligibility

About

The aim of this prospective study was to compare the 5-year prognostic value of transient elastography (TE), FibroTest (FT), APRI , FIB-4, Lok, and Child-Pugh scores for predicting survival and complications of cirrhosis in patients with chronic liver diseases.

Full description

A total of 1616 patients with chronic hepatitis C was included. At 5 years, 79 patients were dead (39 liver-related deaths) and 16 patients had liver transplantation. Overall survival was 91.7% and survival without liver-related death 94.4%. Survival was significantly decreased in patients diagnosed with severe fibrosis, whatever the non-invasive method used. All these methods were able to predict a shorter survival in this large population. Patients had their prognosis decreased as liver stiffness increased. By multivariate analysis, only FibroTest > 0.74 (OR 4.41, 95%CI 1.62-12.01, p=0.004) was associated with overall survival, and liver stiffness > 9.5 kPa (OR 4.71, 95%CI 1.06-21.01, p=0.04) associated with liver-related death.

Enrollment: 1,830 patients

Sex: All

Ages: 18 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• chronic hepatitis C
• chronic hepatitis B
• alcoholic liver disease
• non alcoholic steatohepatitis

Exclusion criteria

• ascitis

Trial design

1,830 participants in 1 patient group

Chronic liver disease

Description:

All patients with chronic liver disease followed using FibroScan and non-invasive markers